| Date Filed | Type | Description |
| 10/05/2018 |
GN
| Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen) |
| 07/12/2018 |
GN
| Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details |
| 06/12/2018 |
GN
| Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental — What Drives Growth in Today's Competitive Landscape |
| 04/13/2018 |
GN
| Express Scripts Holding Company Announces First Quarter 2018 Earnings Release Details |
| 02/21/2018 |
GN
| Recent Analysis Shows EchoStar, Toro, Genesee & Wyoming, Express Scripts Holding, D.R. Horton, and Mirati Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth |
| 01/15/2018 |
GN
| Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call |
| 12/05/2017 |
GN
| New Research: Key Drivers of Growth for Express Scripts Holding, D.R. Horton, Mirati Therapeutics, EchoStar, Toro, and Genesee & Wyoming — Factors of Influence, Major Initiatives and Sustained Production |
| 11/22/2017 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 11/20/2017 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 11/14/2017 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 11/06/2017 |
GN
| Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Analyst Ratings |
| 09/05/2017 |
GN
| Express Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call |
| 07/06/2017 |
GN
| Express Scripts Holding Company Announces Second Quarter 2017 Earnings Conference Call |
| 04/11/2017 |
GN
| Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call |
| 06/30/2016 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 06/29/2016 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 02/24/2016 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 02/22/2016 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 02/12/2016 |
SC 13G
| Capital World Investors reports a 6.6% stake in Express Scripts, Incorporated |
| 06/04/2014 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 06/02/2014 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 02/12/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/07/2012 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 12/07/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/09/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/04/2012 |
PRN
| Express Scripts to Present at Bank of America Merrill Lynch Conference |
| 04/12/2012 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/11/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|